Q4 2025 and Recent Highlights
- Recently began volume production of a custom piezoelectric sensor solution now deployed in the rapidly expanding autonomous vehicle market.
- Now shipping a second-generation custom FSR solution for a leading robotic-assisted surgery platform.
- Continued expansion of our presence as a trusted provider of printed electrode solutions in the healthcare diagnostics market.
- Added two Senior Business Development Directors in
January 2026 to drive organic growth inNorth America andEurope . - Successful conversion of our preferred stock into common stock in
October 2025 , eliminating$400,000 of preferred stock dividends annually.
“We are excited about our momentum with both new and existing customers,” said
Consolidated Financial Results
(Amounts in thousands except per share data and percentages)
| Three Months Ended | Year Ended | ||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | $ ? | % ? | 2025 | 2024 | $ ? | % ? | ||||||||||||||||||||||||||||||||
| Revenue | $ | 2,853 | $ | 2,986 | $ | (133 | ) | (4.5 | ) | % | $ | 11,890 | $ | 11,679 | $ | 211 | 1.8 | % | |||||||||||||||||||||
| Gross profit | $ | 905 | $ | 1,183 | $ | (278 | ) | (23.5 | ) | % | $ | 4,630 | $ | 4,846 | $ | (216 | ) | (4.5 | ) | % | |||||||||||||||||||
| Gross margin | 31.7 | % | 39.6 | % | 38.9 | % | 41.5 | % | |||||||||||||||||||||||||||||||
| (Loss) from operations | $ | (733 | ) | $ | (510 | ) | $ | (223 | ) | $ | (1,829 | ) | $ | (2,050 | ) | $ | 221 | ||||||||||||||||||||||
| Net (loss) | $ | (574 | ) | $ | (413 | ) | $ | (161 | ) | $ | (1,615 | ) | $ | (1,984 | ) | $ | 369 | ||||||||||||||||||||||
| Net (loss) applicable to common stockholders | $ | (607 | ) | $ | (513 | ) | $ | (94 | ) | $ | (1,948 | ) | $ | (2,384 | ) | $ | 436 | ||||||||||||||||||||||
| Earnings (loss) per common share – diluted | $ | (0.04 | ) | $ | (0.03 | ) | $ | (0.01 | ) | $ | (0.13 | ) | $ | (0.16 | ) | $ | 0.03 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | (511 | ) | $ | (233 | ) | $ | (278 | ) | $ | (885 | ) | $ | (1,072 | ) | $ | 187 | ||||||||||||||||||||||
Revenue for the fourth quarter of 2025 decreased 5% to
Gross margin for the fourth quarter of 2025 was 31.7%, versus 39.6% for the fourth quarter of last year. The decline is primarily due to lower revenue and changes in the mix of our products and services, and also in part due to strengthened Chinese yuan relative to the US dollar which increased the cost of our production activities in
Net loss for the fourth quarter of 2025 was
Adjusted EBITDA, a non-GAAP financial measure, was
About
We serve our international customer base from our corporate headquarters and proprietary gas sensor production and product development facility in
For more information, please visit www.InterlinkElectronics.com.
Forward Looking Statements
This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be generally identified by phrases such as “thinks,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” and similar words. Forward-looking statements in our press releases include statements about our projected financial and operating performance, our acquisition program, our strategy and prospects, and our opportunities for organic growth and synergies. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management’s own knowledge and assessment of the company’s industry, R&D initiatives, competition and capital requirements. Other factors and uncertainties that could affect the company’s forward-looking statements include, among other things, the following: our success in predicting new markets and the acceptance of our new products; efficient management of our infrastructure; the pace of technological developments and industry standards evolution and their effect on our target product and market choices; the effect of outsourcing technology development; changes in the ordering patterns of our customers; a decrease in the quality and/or reliability of our products; protection of our proprietary intellectual property; competition by alternative sophisticated as well as generic products; continued availability of raw materials for our products at competitive prices; disruptions in our manufacturing facilities; risks of international sales and operations including fluctuations in exchange rates and tariffs; compliance with regulatory requirements applicable to our manufacturing operations; and customer concentrations. Additional factors that could cause actual results to differ materially from those anticipated by our forward-looking statements are described under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our most recent Annual Report (Form 10-K) or Quarterly Report (Form 10-Q) filed with the Securities and Exchange Commission. Forward-looking statements are made as of the date of the respective release, and we expressly disclaim any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Non-GAAP Financial Measure
To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with
We define Adjusted EBITDA for a particular period as net income (loss) before interest, taxes, depreciation and amortization, and as further adjusted for stock-based compensation expense.
We use this non-GAAP financial measure for financial and operational decision-making and as a means to evaluate period-to-period comparisons. We believe that this non-GAAP financial measure provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our core business operating results, such as amortization expense related to our recent acquisitions. We believe that both management and investors benefit from referring to this non-GAAP financial measure in assessing our performance and when planning, forecasting, and analyzing future periods. This non-GAAP financial measure also facilitates management’s internal comparisons to our historical performance and liquidity as well as comparisons to our competitors’ operating results. We believe this non-GAAP financial measure is useful to investors both because (1) it allows for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) it is used by our investors to help them analyze the health of our business.
There are a number of limitations related to the use of non-GAAP financial measures. We compensate for these limitations by providing specific information regarding the GAAP amounts excluded from these non-GAAP financial measures and evaluating these non-GAAP financial measures together with their relevant financial measures in accordance with GAAP.
Company Contact:
LINK@IESensors.com
805-623-4184
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) | ||||||||
| 2025 | 2024 | |||||||
| (in thousands, except par value) | ||||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 2,724 | $ | 2,950 | ||||
| Accounts receivable, net | 1,542 | 1,612 | ||||||
| Inventories | 1,801 | 2,009 | ||||||
| Prepaid expenses and other current assets | 236 | 328 | ||||||
| Total current assets | 6,303 | 6,899 | ||||||
| Property, plant and equipment, net | 474 | 411 | ||||||
| Intangible assets, net | 1,333 | 1,874 | ||||||
| 2,586 | 2,658 | |||||||
| Right-of-use assets | 760 | 1,064 | ||||||
| Deferred tax assets | 202 | 82 | ||||||
| Other assets | 80 | 128 | ||||||
| Total assets | $ | 11,738 | $ | 13,116 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities | ||||||||
| Accounts payable | $ | 985 | $ | 573 | ||||
| Accrued liabilities | 330 | 377 | ||||||
| Lease liabilities, current | 324 | 352 | ||||||
| Accrued income taxes | 24 | 88 | ||||||
| Total current liabilities | 1,663 | 1,390 | ||||||
| Long-term liabilities | ||||||||
| Lease liabilities, long term | 493 | 777 | ||||||
| Deferred tax liabilities | 361 | 456 | ||||||
| Total long-term liabilities | 854 | 1,233 | ||||||
| Total liabilities | 2,517 | 2,623 | ||||||
| Stockholders’ equity | ||||||||
| Preferred stock | — | 2 | ||||||
| Common stock | 16 | 15 | ||||||
| Additional paid-in-capital | 62,594 | 62,308 | ||||||
| Accumulated other comprehensive income | 406 | 15 | ||||||
| Accumulated deficit | (53,795 | ) | (51,847 | ) | ||||
| Total stockholders’ equity | 9,221 | 10,493 | ||||||
| Total liabilities and stockholders’ equity | $ | 11,738 | $ | 13,116 | ||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) | ||||||||||||||||
| Three Months Ended | Year Ended | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (in thousands, except per share data) | ||||||||||||||||
| Revenue | $ | 2,853 | $ | 2,986 | $ | 11,890 | $ | 11,679 | ||||||||
| Cost of revenue | 1,948 | 1,803 | 7,260 | 6,833 | ||||||||||||
| Gross profit | 905 | 1,183 | 4,630 | 4,846 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Engineering, research and development | 353 | 480 | 1,504 | 2,052 | ||||||||||||
| Selling, general and administrative | 1,285 | 1,213 | 4,955 | 4,844 | ||||||||||||
| Total operating expenses | 1,638 | 1,693 | 6,459 | 6,896 | ||||||||||||
| (Loss) from operations | (733 | ) | (510 | ) | (1,829 | ) | (2,050 | ) | ||||||||
| Other income (expense), net | (10 | ) | 64 | 23 | 93 | |||||||||||
| (Loss) before income taxes | (743 | ) | (446 | ) | (1,806 | ) | (1,957 | ) | ||||||||
| Income tax expense (benefit) | (169 | ) | (33 | ) | (191 | ) | 27 | |||||||||
| Net (loss) | $ | (574 | ) | $ | (413 | ) | $ | (1,615 | ) | $ | (1,984 | ) | ||||
| Net (loss) applicable to common stockholders | $ | (607 | ) | $ | (513 | ) | $ | (1,948 | ) | $ | (2,384 | ) | ||||
| Earnings (loss) per common share – basic and diluted | $ | (0.04 | ) | $ | (0.03 | ) | $ | (0.13 | ) | $ | (0.16 | ) | ||||
| Weighted average common shares outstanding – basic and diluted | 15,289 | 14,796 | 14,924 | 14,793 | ||||||||||||
RECONCILIATION OF CONSOLIDATED NET LOSS TO CONSOLIDATED ADJUSTED EBITDA (unaudited) | ||||||||||||||||
| Three Months Ended | Year Ended | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (in thousands) | ||||||||||||||||
| Net (loss) | $ | (574 | ) | $ | (413 | ) | $ | (1,615 | ) | $ | (1,984 | ) | ||||
| Adjustments to arrive at earnings before interest, taxes, depreciation, and amortization (EBITDA): | ||||||||||||||||
| Interest (income) | (2 | ) | (8 | ) | (20 | ) | (54 | ) | ||||||||
| Income tax expense (benefit) | (169 | ) | (33 | ) | (191 | ) | 27 | |||||||||
| Depreciation expense | 49 | 32 | 190 | 143 | ||||||||||||
| Amortization expense | 177 | 182 | 717 | 753 | ||||||||||||
| EBITDA | (519 | ) | (240 | ) | (919 | ) | (1,115 | ) | ||||||||
| Adjustments to arrive at Adjusted EBITDA: | ||||||||||||||||
| Stock-based compensation expense | 8 | 7 | 34 | 43 | ||||||||||||
| Adjusted EBITDA | $ | (511 | ) | $ | (233 | ) | $ | (885 | ) | $ | (1,072 | ) | ||||
